Biodelivery Sciences International

Pharmaceutical company focusing in the areas of pain management and addiction medicine.

Based in NC

🤖

AI Overview

With $570K in lobbying spend across 18 quarterly filings, Biodelivery Sciences International is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2022.

$570K
Total Spend
5
Years Active
1
Firms Hired
7
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$150K
2019$120K
2020$120K
2021$120K
2022$60K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Biodelivery Sciences International disclosed contacting in their lobbying filings.

Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)SENATECenters For Disease Control & Prevention (CDC)Centers For Medicare and Medicaid Services (CMS)Food & Drug Administration (FDA)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Issues related to the opioid addiction epidemic

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.